Reid Hoffman is stepping down from Microsoft's board after a decade, to concentrate on his AI-driven drug discovery startup, Manus. Hoffman joined Microsoft’s board following its acquisition of LinkedIn in 2016 and was involved in key AI investments, including OpenAI and his own startup Inflection AI. Manus, which raised over $50 million, aims to advance AI in chemistry to fight cancers, with Hoffman as co-founder and chairman. He plans to return to "founder mode" to accelerate progress at Manus, led by CEO Dr. Siddhartha Mukherjee.
Goldman Sachs projects annual AI capital spending to reach $765 billion by 2026 and $1.6 trillion by 2031, driving growth in AI-focused investment funds. Three active or active-leaning ETFs—iShares A.I. Innovation and Tech Active ETF (BAI), iShares F...
Reid Hoffman, co-founder of LinkedIn and a key figure in Microsoft's partnership with OpenAI, will not seek re-election to Microsoft's board this year. Hoffman cited his desire to focus on a startup he co-founded that is advancing AI technology for c...
New analysis from TS Lombard predicts that the US will invest about 2% of its GDP in artificial intelligence and data center infrastructure in 2026, totaling up to $800 billion. This investment surpasses that of any other country and is comparable to...
Apple and Alphabet are currently best positioned in the AI industry, generating strong positive free cash flow despite increased capital expenditures across the sector. In contrast, companies like Microsoft, Amazon, Meta, and Oracle are experiencing ...
Investor Bill Ackman compares today's mega-cap stocks to Berkshire Hathaway during the dot-com bubble, suggesting they are undervalued as the market chases new AI trends. He highlights Microsoft, Meta, and Amazon as key players benefiting from AI's g...
